Abstract
Malaria is an infectious disease caused by parasites of the genus Plasmodium, and is among the most serious in the developing world, resulting in an estimated 200 million cases and 1.2 million deaths in 2010 1 . The majority of cases and mortality are due to P. falciparum in sub-Saharan Africa, whilst P. vivax is widespread and causes persistent infections 2 . Resistance has been recorded against all frontline therapies, and the need for new drugs is widely recognized 3 . N-Myristoyltransferase (NMT, EC 2.3.1.97) catalyzes transfer of the lipid myristate (C14:0) from myristoyl coenzyme A (Myr-CoA) to specific substrate proteins in eukaryotes 4 , and has been explored preclinically as a target in fungal 5 and trypanosome infections 6 , and suggested as a potential target in malaria and leishmaniasis 7 . Protein N-myristoylation occurs predominantly co-translationally at an N-terminal glycine following removal of initiator methionine (Fig. 1a) ; although an N-terminal glycine is essential, there is no panspecies consensus sequence for myristoylation 4 . In silico analyses suggest that up to 2% of proteins in P. falciparum may be substrates for NMT (Supplementary   Table S1 ), although lack of suitable training sets for Plasmodium myristoylation results in inconsistent predictions 8 . To date, only two proteins have been shown to be N-myristoylated in their native context in P. falciparum -calcium-dependent protein kinase-1 (CDPK1) 9 and glideosome-associated protein 45kDa (GAP45) 10 - and there is indirect evidence for a small number of other substrates 10, 11, 12, 13 . NMyristoylation regulates membrane localization and protein complex assembly in eukaryotes 14 , and selective inhibition of NMT is hypothesized to lead to pleiotropic effects on the parasite through multiple downstream substrates. Plasmodium species possess a single NMT gene 15 and partial knockdown of NMT expression in the rodent malaria parasite P. berghei was found to result in rapid depletion of parasitemia in vivo, demonstrating that NMT is essential in this murine model of 4 malaria 16 . However, target validation in human malarial parasites is particularly challenging due to their complex life cycle, the limited range of genetic tools available, and the very low efficiency of genetic modification 17 . Despite intensive research efforts, conditional genetic knockout of an essential gene in P. falciparum has not been demonstrated to date, and thus chemical genetic knockdown approaches based on small molecule inhibitors are a particularly powerful and versatile strategy for target validation.
Here we present an integrated chemical biology approach to understand inhibition of N-myristoylation in P. falciparum parasites that enables both the study of protein myristoylation and the chemical dissection of NMT as a drug target in this genetically intractable organism. These studies greatly expand knowledge of both N-
myristoylated and glycosylphosphatidylinositol (GPI) anchored proteins in
Plasmodium, and provide the first compelling evidence that NMT is a druggable target in the symptomatic blood stage of the most important human malaria parasite.
Using these tools in combination with quantitative whole proteome analyses and cellular studies, we demonstrate that NMT inhibition results in a catastrophic and irreversible failure to form critical parasite subcellular structures, followed by rapid parasite cell death. Furthermore, we define potent starting points for the development of NMT inhibitors as potential antimalarials that are active against human malaria parasites in vitro, and in vivo in an animal model of malaria.
Results
Myristoyl-CoA analogue YnMyr-CoA is a biomimetic substrate for Plasmodium
NMT
Lipid probes bearing a bioorthogonal tag such as a terminal alkyne are powerful tools for analysis of protein lipidation in living systems 18, 19 . The myristate surrogate tetradec-13-ynoic acid (YnMyr) can be transferred from YnMyr-CoA thioester to target proteins by recombinant NMT 20 , in bacterial co-expression systems 21 or in mammalian cells 22 . Subsequent chemoselective ligation through copper(I)-catalyzed
[3+2] azide-alkyne cycloaddition (CuAAC) imparts a range of useful functionality to tagged proteins, including a fluorophore and/or affinity label (Fig. 1b ) 20, 22, 23, 24 . We determined the structure of NMT from P. vivax (PvNMT, which shares >80% identity with P. falciparum NMT (PfNMT)) 25 in complex with YnMyr-CoA (PDB 2YNC; Supplementary Fig. S1 and Table S2 ), revealing that YnMyr-CoA occupies an extended groove that runs across one face of the enzyme, with the YnMyr chain occupying the fatty acyl binding pocket (Fig. 1c) . The terminal sp hybridized carbon atoms are accommodated without steric clashes and the hydrophobic contacts and native interactions of the thioester carbonyl with backbone amide and polar side chain moieties are preserved (Fig. 1c) 
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. This structure is the first reported example of a tagged analogue of a post-translational modification precursor in complex with its cognate transferase, and together with kinetic data (Supplementary Fig. S2) indicates that a terminal alkyne moiety is fully compatible with enzymatic transfer of YnMyr to substrate proteins. Fig. S3 ) 27 enabled direct in-gel fluorescence detection of protein tagging following SDS PAGE ( Fig. S5 ). The known N-myristoylated proteins CDPK1 and GAP45 10, 28 were selectively pulled down from parasites cultured in the presence of YnMyr, and resistance of labeling to base and hydroxylamine indicated the presence of N-acyl (amide linked) YnMyr ( Fig. 2a and Supplementary Fig. S6 ). Control experiments cross-comparing metabolic incorporation of the longer chain palmitate probe YnPal (heptadec-14-ynoic acid) confirmed that YnMyr was not significantly incorporated into sites of S-palmitoylation, which occurs through a thioester linked to cysteine side chains (Supplementary Fig. S7 ). However, a substantial fraction of the fluorescently labeled bands were base sensitive suggesting the presence of ester-linked YnMyr (Fig. 2a) . Ester-linked incorporation of myristate at the GPI 7 anchor inositol is characteristic of Plasmodium species 29 , and we found that the abundant GPI-anchored surface protein MSP1 was indeed tagged by YnMyr in a base-sensitive manner (Fig. 2a) . Taken together, these data suggest that YnMyr is a high-fidelity myristate mimetic in live parasites, and can be used as a probe for both N-myristoylated and GPI-anchored proteins under standard culture conditions.
YnMyr tags N-myristoylated
Chemical proteomic profiling of N-myristoylated and GPI-anchored proteins in
P. falciparum
We next performed de novo identification of YnMyr targets in P. falciparum by LC-MS/MS based chemical proteomics after AzTB ligation, pull-down and protein digest, using both gel-based and gel-free approaches. Tryptic peptides were analyzed by a standard proteomics workflow, and proteins found with very high (>99 %) confidence and >4-fold enrichment compared to controls were considered for further analysis;
proteomic methods are described in detail in Supplementary Methods. NMyristoylated target proteins were mapped to specific regions of the gel following gel-based proteomics ( Fig. 2b; Supplementary Fig. S8 and Table S6 ), identifying ADP-ribosylation factor 1 (ARF1) as the major component of the strongest fluorescent band. A novel antibody directed against PfARF1 further confirmed this assignment (Fig. 2c) . Base-treatment prior to pull-down was used to dissect the contributions of GPI-anchored and N-myristoylated proteins; identification of MSP1 and predicted GPI-anchored proteins was dramatically reduced or eliminated by base treatment, whilst putative N-myristoylated proteins were unaffected ( Fig. 3a; Supplementary Tables S3, S4 and S5) 30, 31 . YnMyr-tagged peptides were not detected in these analyses, due to the presence of the biotin label added during CuAAC ligation that anchors the peptide to the resin during tryptic digest. Indeed, direct determination of the site of modification has been recognized as a significant unsolved challenge in metabolic tagging of lipidated proteins 32 due to poor release of the biotinylated peptide from the streptavidin resin and the large size of the resultant label. We therefore designed a new tetra-functional capture reagent (AzKTB, Fig.   3b ) which bears a short trypsin-cleavable peptide sequence between the azide module and the TAMRA/PEG-biotin labels. Tryptic on-bead digest releases the YnMyr-modified peptide bearing a hydrophilic zwitterionic moiety, permitting the site of YnMyr modification to be determined unambiguously by tandem MS (Supplementary Fig. S9 ). Using this new approach, 17 N-terminal YnMyr-Gly motifs were detected ( Fig. 3a and Supplementary Table S7) , further confirming the fidelity of the YnMyr probe for NMT substrates in live parasites.
Taken together, these data provide direct experimental evidence for more than 30
NMT substrates in wild type parasites, encompassing a diverse range of functions including motility, protein transport, parasite development and phosphorylation pathways ( Fig. 3c) . As expected, many substrates have predicted or known localization at membranes or in membrane-bound compartments (Supplementary ; however, the causative agents of malaria and trypanosomiasis have entirely different mechanisms of infection and disease pathology. Series 2 is derived from a P. falciparum NMT inhibitor based on a benzothiophene scaffold, 40 the structure-guided development of which will be reported elsewhere in due course. X-ray crystallography was used to determine the binding mode of the most potent compounds 1a and 2a in ternary complexes with PvNMT and a non-hydrolyzable myristoyl-CoA analogue (PDB 2YND and 2YNE; Supplementary Table S2 ). Both inhibitors bind at the peptide binding pocket, with 1a exhibiting a similar binding mode to that observed in NMTs from other species ( Fig. 4b and Supplementary Fig. S11 ). A salt bridge is formed between the positively charged piperazine (1a) or piperidine (2a) nitrogen and the Cterminal carboxylate of the enzyme, which plays an essential catalytic role during myristate transfer 4 . Despite this common point of contact, the trajectory of these two chemotypes through the binding site is distinct. Substitution of the trimethyl pyrazole (1c, 2b) substantially reduces potency, likely due to reduced H-bonding capacity, whilst sulfonamide alkylation in 1b yielded a more subtle decrease (Fig. 4a) .
Although 1a-c 41 ) varied significantly across series (Fig. 5a) . Uninfected RBCs remained morphologically normal (Supplementary Fig. S12 ). Since protein N-myristoylation occurs co-translationally we reasoned that inhibition of NMT in parasites could be assessed directly by treatment with inhibitor combined with pulse tagging with YnMyr. When tagging experiments were repeated in the presence of 1a a highly specific dose-dependent depletion of fluorescence was observed for all bands previously identified as NMT substrates, with no change in GPI-anchored proteins ( Fig. 5b; Supplementary Figs. S13 and S14). Parallel experiments with the tagged methionine surrogate azidohomoalanine (AHA 43 , Supplementary Fig. S3 ) showed that 1a does not directly affect protein synthesis (Supplementary Fig. S15 ). Selective inhibition was further confirmed for specific substrate proteins by Western blot against CDPK1 and GAP45, and using novel antibodies directed against ARF1 and ARO ( Fig. 5b; Supplementary Figs. S16 and S17). Fig. 5c and Supplementary Fig. S18 ).
Series 1 and 2 were compared for their capacity to knock down NMT activity in parasites with the aim of rationalizing their diverse enzyme to cell translation ( Fig. 5a and Supplementary Figs. S19 and S20 ). An excellent correlation was observed between TC 50 and parasite viability (EC 50 ) across all compounds tested (R 2 = 0.97, values for parasite killing (Fig. 5a ). These data demonstrate that 1a-c and 2a-b 12 possess the same on-target mode of action, and establish the chemical tractability of NMT in blood stage human malaria parasites.
We also examined the impact of NMT inhibition on parasite burden in vivo in the rodent malaria parasite P. berghei. Both 1a and 2a maintained reasonable potency against recombinant PbNMT (K i = 90 and 14 nM, respectively), but initial experiments found that 1a induced toxicity in vivo at sub-therapeutic concentrations.
However, when 2a was administered to infected mice a significant (p ≤ 0.01, n = 3) reduction in parasitemia was observed compared to controls (PBS vehicle) over the course of 3 days treatment (50 mg/kg intraperitoneally, twice daily) (Fig. 5d) .
Furthermore, 2a caused no acute toxicity and animals survived without visible symptoms past day 3, whereas all control mice needed to be euthanized due to acute symptoms of malaria. This first demonstration of in vivo activity of a chemical inhibitor of Plasmodium NMT is encouraging, particularly given that the potency and pharmacokinetic properties of 2a are suboptimal (Supplementary Table S8 ).
NMT inhibition results in formation of non-viable parasites lacking critical components required for development and RBC invasion
Having confirmed on-target action of NMT inhibitors in parasites, we sought to use these tools to investigate how NMT inhibition leads to parasite cell death. During asexual reproduction, P. falciparum undergoes a 45-48 hour life cycle within infected RBCs (iRBCs), maturing from ring stage, to trophozoite, and then schizont, before differentiation into merozoites that egress and reinvade RBCs (Fig. 6a) . We examined the effects of NMT inhibition on life stage progression, monitoring growth at 1 µM 1a, a dose that causes approximately 80% inhibition of protein myristoylation in parasites (Fig. 5) . NMT inhibitor or DMSO vehicle (control) was added to highly ) multinucleate parasites contained 4-7 (5.6 ± 1.1) nuclei in the presence of 1a, compared to ca. 20 (19.6 ± 2.7) nuclei in control schizonts ( Fig. 6a and Supplementary Fig. S21 ). The clarity and severity of this phenotype is striking given that 1a was applied at a concentration that does not completely eliminate NMT activity in cells, and is consistent with the observed high sensitivity of parasites towards NMT inhibition ( Fig. S22 ).
In order to characterize the distinguishing features of pseudoschizonts, we performed a quantitative proteomic analysis in pseudoschizonts (inhibitor-treated) and schizonts (control) at 45 hours PI. The relative abundance of 1181 parasite proteins was determined through label-free quantification, revealing a conspicuous clustering amongst strongly affected proteins with known function (Fig. 6b and 
Supplementary Table S9). Multiple markers of the Inner Membrane Complex (IMC)
were greatly reduced in abundance in inhibited cells (e.g. MyoA, MTIP, GAP45, ISP3), as were a set of late-expressed proteins specific to apical (secretory) organelles in developing merozoites; these included ARO, PTRAMP and key RBC binding proteins and antigens (e.g. EBA140/175/181, RH2a). Western blot analyses of GAP45, MTIP, CDPK1 and ARO further confirmed marked depletion of these proteins in pseudoschizonts (Fig. 6c) . Interestingly, there was relative accumulation of a set of soluble secreted proteins, including several members of the serine repeat antigen family (SERA) which under normal conditions are exported and processed during schizont development.
The IMC is comprised of flattened membrane compartments lying directly under the plasma membrane, where one of its roles is assembly of the molecular motor complex (including MTIP, MyoA and GAP45) that drives invasion of RBCs. In the intracellular parasite, assembly of the IMC occurs during schizogony and can be visualised with protein markers such as GAP45 44 . In Plasmodium nuclear division precedes cell division, and the IMC initially appears as small ring-like structures, which then extend around developing merozoites during schizont segmentation (cell division). This transition was recapitulated in immunofluorescence images of DMSOtreated parasites at 35 and 45 hours PI, whereas in the inhibitor treated parasites the IMC structure was not visible at either time point (Fig. 6d) . Given the established importance of the IMC in parasite development and invasion, we hypothesized that NMT inhibition-induced loss of the IMC would have catastrophic and irreversible consequences for parasite viability. Indeed, when inhibited parasites (1 µM 1a) were analyzed 10 hours later (at 55 hours PI), iRBCs bearing pseudoschizonts were largely eliminated even when inhibitor was removed at 45 hours PI, whereas control parasites egressed and reinvaded new RBCs to form new ring stages over the same timeframe (Fig. 6e) .
Discussion
Here ; it also has an essential role in organizing the acto-myosin motor that drives invasion of RBCs 44 .
We recently demonstrated that P. berghei ISP1 and ISP3 are highly expressed in invasive stages, and localize to the anterior apical end of the parasite where IMC organization is initiated 39 . Whilst deletion of ISP3 in P. berghei is compensated by up-regulation of ISP1, NMT inhibition may result in simultaneous inactivation of both proteins through loss of the membrane anchor. Loss of the IMC is sufficient to explain the irreversible and cidal mode of action of PfNMT inhibition during early schizogony, and failure to develop into infective merozoites. However, the comparative whole-proteome dataset obtained here shows that this is far from the only phenotype arising from PfNMT inhibition, and provides a rich resource that can be mined to initiate future studies of IMC formation, protein trafficking and assembly of the invasion apparatus.
Chemical knockdown of PfNMT effectively combines the benefits of a selective enzyme inhibitor with a defined multi-target, pleiotropic downstream mode of action.
We have shown here that P. falciparum is highly sensitive to a global drop in Nmyristoylation, and structural characterization of the binding modes of inhibitors at the protein substrate binding pocket of Plasmodium NMT provides the potential for future improvements in potency and selectivity through structure-guided design.
Remarkably, despite unoptimized pharmacokinetic (PK) properties and modest in vitro potency, NMT inhibitor 2a significantly reduced parasitemia in the rodent model P. berghei with no acute toxicity, providing further evidence for the druggability of NMT in malaria. This in vivo proof of principle suggests that compounds with improved potency and PK properties could form the basis for an antimalarial drug discovery program 46 .
In future studies, the chemical tools described here may be applied to examine the 
Chemical probes
Synthesis of YnMyr, YnPal, AzTB and YnTB has been described previously 20, 27 .
AHA was purchased from Iris Biotech. Synthesis of other compounds is described in the Supplementary Methods.
Parasite culture
Parasites were cultured as described previously and schizont stages purified using magnetic columns (MACS), 48 before returning to culture for 2-4 h and synchronizing the newly invaded ring-stage parasites with 5 % D-sorbitol, 49 one cycle prior to use.
YnMyr tagging and labeling
For tagging, assays were set up using parasites at 40 h post invasion (based on initial Giemsa-stained smear observations) and diluted to ~10 % parasitemia. A haematocrit of 4 % was used to increase the total number of parasites harvested. To CuAAC bioorthogonal ligation and pull-down of labeled proteins was carried out essentially as previously described 21 ; full details are given in Supplementary Methods, along with details of in-gel fluorescence imaging and immunoblot analysis.
Proteomic identification of YnMyr tagged proteins by LC-MS/MS
Following CuAAC ligation and pull-down, samples were reduced, alkylated and digested on-bead with trypsin, as described in the Supplementary Methods. LC-MS/MS was carried out using an RSLCnano HPLC system (Dionex, UK) and an LTQ-Orbitrap-Velos mass spectrometer (Thermo Scientific). Data were further processed using Mascot (version 2.2.04, Matrix Science Ltd.) and Scaffold (version 3.6.02, Proteome Software). Protein identifications were required to contain at least 2 peptides exceeding 95 % probability giving a calculated protein false discovery rate of 0.0 %. Further experimental details and a description of data analysis are given in the Supplementary Methods. 
Proteomics analysis of inhibited parasites

